BRIEF-Xoma Royalty And Lava Therapeutics Announce Amendment To Purchase Agreement

Reuters

Oct 17

BRIEF-Xoma Royalty And Lava <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announce Amendment To Purchase Agreement

Oct 17 (Reuters) - XOMA ROYALTY:

XOMA ROYALTY AND LAVA THERAPEUTICS ANNOUNCE AMENDMENT TO PURCHASE AGREEMENT
XOMA ROYALTY CORP: LAVA SHAREHOLDERS WHO TENDER THEIR SHARES WILL NOW RECEIVE AN INITIAL CASH AMOUNT PER SHARE OF $1.04
XOMA ROYALTY CORP: AMENDMENT TO AGREEMENT WITH LAVA INCLUDES UPDATED CVR TERMS FOR TENDER OFFER

Source text: ID:nGNX8lKj3Z

Further company coverage: XOMA.OLVTX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2576529280"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2576529280\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2576529280?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-17 23:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2576529280","market":"fut","top_or_hot":-1,"title":"BRIEF-Xoma Royalty And Lava Therapeutics Announce Amendment To Purchase Agreement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Xoma Royalty And Lava <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Announce Amendment To Purchase Agreement</title></head><body><p><span>Oct 17 (Reuters)</span><span> - </span>XOMA ROYALTY:</p><ul><li><p>XOMA ROYALTY AND LAVA THERAPEUTICS ANNOUNCE AMENDMENT TO PURCHASE AGREEMENT</p></li><li><p>XOMA ROYALTY CORP:  LAVA SHAREHOLDERS WHO TENDER THEIR SHARES WILL NOW RECEIVE AN INITIAL CASH AMOUNT PER SHARE OF $1.04</p></li><li><p>XOMA ROYALTY CORP:  AMENDMENT TO AGREEMENT WITH LAVA INCLUDES UPDATED CVR TERMS FOR TENDER OFFER</p></li></ul><p>Source text: <span>ID:nGNX8lKj3Z</span></p><p>Further company coverage: <span>XOMA.O</span><span>LVTX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Xoma Royalty And Lava Therapeutics Announce Amendment To Purchase Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Xoma Royalty And Lava Therapeutics Announce Amendment To Purchase Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-17 23:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Xoma Royalty And Lava <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Announce Amendment To Purchase Agreement</title></head><body><p><span>Oct 17 (Reuters)</span><span> - </span>XOMA ROYALTY:</p><ul><li><p>XOMA ROYALTY AND LAVA THERAPEUTICS ANNOUNCE AMENDMENT TO PURCHASE AGREEMENT</p></li><li><p>XOMA ROYALTY CORP:  LAVA SHAREHOLDERS WHO TENDER THEIR SHARES WILL NOW RECEIVE AN INITIAL CASH AMOUNT PER SHARE OF $1.04</p></li><li><p>XOMA ROYALTY CORP:  AMENDMENT TO AGREEMENT WITH LAVA INCLUDES UPDATED CVR TERMS FOR TENDER OFFER</p></li></ul><p>Source text: <span>ID:nGNX8lKj3Z</span></p><p>Further company coverage: <span>XOMA.O</span><span>LVTX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nTUA4DPBKR:1","article_id":"2576529280","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2576529280","pubTimestamp":1760716178,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Xoma Royalty And Lava Therapeutics Announce Amendment To Purchase AgreementOct 17 (Reuters) - XOMA ROYALTY:XOMA ROYALTY AND LAVA THERAPEUTICS ANNOUNCE AMENDMENT TO PURCHASE AGREEMENTXOMA ROYALTY","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","XOMA":"标记临床研究","LVTX":"LAVA Therapeutics N.V.","BK4539":"次新股"},"translate_title":"简报-Xoma Royalty和Lava Therapeutics宣布修改购买协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LVTX":0.9,"XOMA":0.9},"content_text":"BRIEF-Xoma Royalty And Lava Therapeutics Announce Amendment To Purchase AgreementOct 17 (Reuters) - XOMA ROYALTY:XOMA ROYALTY AND LAVA THERAPEUTICS ANNOUNCE AMENDMENT TO PURCHASE AGREEMENTXOMA ROYALTY CORP:  LAVA SHAREHOLDERS WHO TENDER THEIR SHARES WILL NOW RECEIVE AN INITIAL CASH AMOUNT PER SHARE OF $1.04XOMA ROYALTY CORP:  AMENDMENT TO AGREEMENT WITH LAVA INCLUDES UPDATED CVR TERMS FOR TENDER OFFERSource text: ID:nGNX8lKj3ZFurther company coverage: XOMA.OLVTX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}